PRECEMTABART
UNII 76DT32W78Z

Substance Identification & Data

This profile provides standardized clinical and technical data for Precemtabart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 76DT32W78Z.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2883118-92-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

76DT32W78Z

CAS Registry Number

2883118-92-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PRECEMTABART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C206970

National Cancer Institute reference terminology for clinical and research data.

INN ID

13071

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-146

Identifier assigned by the United States Adopted Names Council.

Substance Type

Precemtabart

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Precemtabart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Precemtabart

Common Names & Synonyms

Immunoglobulin G1 [235-proline,236-valine,237-alanine,331-serine,332-serine,de-448-lysine], anti-(human carcinoembryonic antigen-related cell adhesion molecule 5) (human monoclonal MBE-748 γ1-chain), disulfide with human monoclonal MBE-748 κ-chain, dimer

PRECEMTABART [USAN]

immunoglobulin G1-kappa, anti-[Homo sapiens CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule 5, CEA, CD66e)], Homo sapiens monoclonal antibody; H-gamma1 heavy chain Homo sapiens (1-447) [VH (Homo sapiens IGHV4-31*02 (90.9%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [10.7.11] (26-35.53-59.98-108)) (1-119) -Homo sapiens IGHG1*03, G1m3, nG1m1 CH1 R120, CH3 E12, M14,G1v50 delE1.4, P1.3, V1.2, A1.1, G1v60 CH2 S115, S116 (CH1 R120 (216) (120-217), hinge 1-15 (218-232), CH2 E1.4>del, L1.3>P (235), L1.2>V (236), G1.1>A (237), A115>S (331), P116>S (332) (233-341), CH3 E12 (357), M14 (359) (342-446), CHS K2>del (447)) (120-447)], (222-214')-disulfide with L-kappa light chain Homo sapiens (1'-214') [V-KAPPA (Homo sapiens IGKV3-15*01 (94.7%) -IGKJ3*01 (100%), CDR-IMGT [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (153'), V101 (191') (108'-214')]; dimer (228-228'':231-231'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1SV, glycoform alfa

precemtabart [INN]

Technical Codes

MBE-748

External Clinical & Regulatory Resources

Previous UNII76DN4S45UC

Next UNII76DXK4XC7R